Home › Funds › Invenomic Capital Management LP › XRAY

Invenomic Capital Management LP position in XRAY

DENTSPLY SIRONA INC · Health Care

Invenomic Capital Management LP reported holding 4,909,808 shares of XRAY (DENTSPLY SIRONA INC) in its Q2 2026 13F filing — a position valued at US$52.1M, representing 3.11% of its reported portfolio and ranking #4 among its reported holdings. Invenomic Capital Management LP has disclosed XRAY holdings in 8 of the last 8 reported quarters, going back to Q3 2024.

Latest position (Q2 2026)4.91M sh
Reported value held$52.09M
Portfolio Weight3.11%
First reportedQ3 2024
Last changeAdd
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Invenomic Capital Management LP's XRAY position evolved

Invenomic Capital Management LP first disclosed a stake in XRAY in Q3 2024 at 876,733 shares (US$23.7M). The position peaked in Q4 2025 at 5,132,036 shares, worth US$58.7M. Across 8 filings, Invenomic Capital Management LP increased the stake 5 time(s), trimmed it 2 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 4,909,808 shares valued at US$52.1M — an increase of 519,715 shares quarter over quarter.. Notable position changes include a 201% increase in Q4 2024 (shares fell 21% over the following quarter), a 49% increase in Q3 2025 (shares fell 10% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2024 876.73K $23.72M New
Q4 2024 2.64M $50.09M Add
Q1 2025 2.48M $37.00M Reduce
Q2 2025 2.93M $46.46M Add
Q3 2025 4.35M $55.22M Add
Q4 2025 5.13M $58.66M Add
Q1 2026 4.39M $50.93M Reduce
Q2 2026 4.91M $52.09M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About XRAY and 13F data

XRAY (DENTSPLY SIRONA INC) is a Health Care company. 13 other funds we track also report a position in XRAY — the largest reported positions include ARIEL INVESTMENTS, LLC (US$85.2M), Southpoint Capital Advisors LP (US$74.3M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding XRAY

All XRAY fund holders →

FAQ

How long has Invenomic Capital Management LP held XRAY?

Invenomic Capital Management LP has disclosed XRAY holdings in 8 of the last 8 reported quarters, going back to Q3 2024.

What is Invenomic Capital Management LP's current position in XRAY?

As of Q2 2026, Invenomic Capital Management LP holds 4.91M shares of XRAY (DENTSPLY SIRONA INC), valued at $52.09M, representing 3.11% of its reported portfolio and ranking #4.

Has Invenomic Capital Management LP been buying or selling XRAY?

In the latest 13F filing (Q2 2026), Invenomic Capital Management LP increased its position in XRAY. The position peaked in Q4 2025 at 5.13M shares.

Which other funds hold XRAY?

Other major institutional holders of XRAY include ARIEL INVESTMENTS, LLC, Southpoint Capital Advisors LP, among 13 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.